Where will LEAP be available?
LEAP will be available worldwide in countries where GSK expects to file or has filed for regulatory approval. When sites have been approved to participate and are activated, patients can start being enrolled into the EAP in those active sites. Activation means the site has met all the Regulatory requirements and received IRB approval. For more information regarding active EAP sites, please refer to the LEAP Global Sites and Contacts section of this website.
